News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
January, 2025
January 2025
M T W T F S S
 12345
6789101112
13141516171819
20212223242526
2728293031  
Advantage of SBRT over Surgery for early-stage NSCLC, study by Jochem Kaas
Jochem Kaas/LinkedIn
Nov 11, 2024, 04:17

Advantage of SBRT over Surgery for early-stage NSCLC, study by Jochem Kaas

Drew Moghanaki, Professor and Chief of Thoracic Oncology at the Department of Radiation Oncology at UCLA, shared an article by Jochem Kaas on X:

 “A new Dutch study demonstrates a clear advantage of SBRT over Surgery for early-stage NSCLC. “

Advantage of SBRT over Surgery for early-stage NSCLC, study by Jochem Kaas

Climate impact of early-stage NSCLC treatment: A comparison between radiotherapy and surgery using Life Cycle Assessment.

Authors: Jochem Kaas, et al.

Advantage of SBRT over Surgery for early-stage NSCLC, study by Jochem Kaas

Drew Moghanaki, a Professor and Chief of Thoracic Oncology at the Department of Radiation Oncology, UCLA. He holds the Stanley Iezman and Nancy Stark Endowed Chair in Thoracic Radiation Oncology Research at the same university. He specializes in treating lung cancer and other thoracic malignancies, focusing on advanced radiation therapy techniques like stereotactic body radiation therapy (SBRT), magnetic resonance-guided radiation therapy (MRgRT), and intensity-modulated radiation therapy (IMRT).

cancer Drew Moghanaki Jochem Kaas NSCLC OncoDaily Oncology radiotherapy RadOnc SBRT UCLA
Special Coverage
Insight
Jan 19, 2025, 05:52
Proffered Paper Oral Presentations session - BGICC
Blog
Jan 19, 2025, 05:49
Estela Rodriguez: New podcast on ASCO Updated Guidelines on the management of pleural mesothelioma
Blog
Jan 19, 2025, 05:47
Jonathan Spicer: An outstanding talk by Cecilia Pompili on early-stage lung cancer at ELIXR24
Blog
Jan 19, 2025, 05:45
Margaret Foti: The medical research community is fortunate to have had Dr. Bertagnolli at the helm of the NIH
Blog
Jan 19, 2025, 05:34
New Bench to Bedside Chats from Project Catalyst’s initiative - FDA Oncology
Blog
Jan 19, 2025, 05:31
Michael White on what makes MD Anderson Cancer Center special
Insight
Jan 19, 2025, 04:47
Loay Kassem: If your patient can't afford a CDK4/6 inhibitor, don't settle down for endocrine therapy alone
Insight
Jan 19, 2025, 04:45
Enrique Grande: Adjuvant Radiation Following Cystectomy
Insight
Jan 19, 2025, 04:13
Survival with Trastuzumab Emtansine in Residual HER2-Positive Breast Cancer
Blog
Jan 19, 2025, 03:06
Yvonne Diaz: AI, wearables and digital tech in clinical research
Societies
Jan 18, 2025, 23:03
Abstract submission system open for the ESMO Gynaecological Cancers 2025
Science
Jan 18, 2025, 23:00
New training modules on pain management in cancer care - Society for Integrative Oncology